[go: up one dir, main page]

DE69835346D1 - Vakzine gegen infektiöse bursitis - Google Patents

Vakzine gegen infektiöse bursitis

Info

Publication number
DE69835346D1
DE69835346D1 DE69835346T DE69835346T DE69835346D1 DE 69835346 D1 DE69835346 D1 DE 69835346D1 DE 69835346 T DE69835346 T DE 69835346T DE 69835346 T DE69835346 T DE 69835346T DE 69835346 D1 DE69835346 D1 DE 69835346D1
Authority
DE
Germany
Prior art keywords
vaccines
oppose
infectious bursitis
bursitis
infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69835346T
Other languages
English (en)
Other versions
DE69835346T2 (de
Inventor
Gerrit Davelaar
Johanna Pitstra
Wiltenburg Nico Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer AG
Original Assignee
Dimminaco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco AG filed Critical Dimminaco AG
Application granted granted Critical
Publication of DE69835346D1 publication Critical patent/DE69835346D1/de
Publication of DE69835346T2 publication Critical patent/DE69835346T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69835346T 1997-02-03 1998-01-29 Vakzine gegen infektiöse bursitis Expired - Lifetime DE69835346T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200298A EP0861665A1 (de) 1997-02-03 1997-02-03 Vakzine gegen Infektiöse Bursitis
EP97200298 1997-02-03
PCT/EP1998/000461 WO1998033522A1 (en) 1997-02-03 1998-01-29 Infectious bursitis vaccine

Publications (2)

Publication Number Publication Date
DE69835346D1 true DE69835346D1 (de) 2006-09-07
DE69835346T2 DE69835346T2 (de) 2006-11-23

Family

ID=8227982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69835346T Expired - Lifetime DE69835346T2 (de) 1997-02-03 1998-01-29 Vakzine gegen infektiöse bursitis

Country Status (17)

Country Link
US (1) US7211260B1 (de)
EP (2) EP0861665A1 (de)
JP (1) JP2001511138A (de)
KR (1) KR100545462B1 (de)
CN (1) CN1178697C (de)
AR (1) AR011108A1 (de)
AT (1) ATE333894T1 (de)
AU (1) AU745477B2 (de)
BR (1) BR9807299B1 (de)
CA (1) CA2278824A1 (de)
CO (1) CO4790102A1 (de)
DE (1) DE69835346T2 (de)
ES (1) ES2268766T3 (de)
IL (1) IL130832A (de)
NZ (1) NZ336937A (de)
WO (1) WO1998033522A1 (de)
ZA (1) ZA98830B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861665A1 (de) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Vakzine gegen Infektiöse Bursitis
EP1161953A3 (de) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV Stamm für in ovo Verabreichung
ZA200104596B (en) 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
KR101560793B1 (ko) 2013-08-20 2015-10-15 주식회사 바이오포아 비병원성 전염성낭병 변이 바이러스 및 이의 백신으로써의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine
IL103939A (en) * 1992-12-01 1996-09-12 Abic Ltd An anti-DBI vaccine in birds containing attenuated live DBI virus
EP0861665A1 (de) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Vakzine gegen Infektiöse Bursitis

Also Published As

Publication number Publication date
AU745477B2 (en) 2002-03-21
CN1178697C (zh) 2004-12-08
ZA98830B (en) 1999-08-02
AR011108A1 (es) 2000-08-02
KR20000070736A (ko) 2000-11-25
EP0861665A1 (de) 1998-09-02
CO4790102A1 (es) 1999-05-31
DE69835346T2 (de) 2006-11-23
IL130832A0 (en) 2001-01-28
ATE333894T1 (de) 2006-08-15
AU6294098A (en) 1998-08-25
BR9807299B1 (pt) 2009-01-13
JP2001511138A (ja) 2001-08-07
CN1246800A (zh) 2000-03-08
CA2278824A1 (en) 1998-08-06
HK1024411A1 (en) 2000-10-13
IL130832A (en) 2005-03-20
ES2268766T3 (es) 2007-03-16
KR100545462B1 (ko) 2006-01-24
NZ336937A (en) 2001-10-26
US7211260B1 (en) 2007-05-01
EP0967991A1 (de) 2000-01-05
EP0967991B1 (de) 2006-07-26
WO1998033522A1 (en) 1998-08-06
BR9807299A (pt) 2000-04-18

Similar Documents

Publication Publication Date Title
NO20003303L (no) Vaksine
DE69800383D1 (de) Influenza Vaccine
FI964592L (fi) Papilloomavirusrokotteita
BR9711853A (pt) Vacinas
NO20014325D0 (no) Vaksine
NO20006191D0 (no) Vaksine
ATE209045T1 (de) Hepatitis b impfstoff
ATE312624T1 (de) Impfstoff gegen hpv
NO20020763D0 (no) Vaksine
FI974166A0 (fi) Foerfarande och anordning foer soekning av en databas
ATE394119T1 (de) Vakzinzusammensetzung gegen malaria
DE59803561D1 (de) Lüfterrad
DK0898969T3 (da) Neospora-vaccine
NO20005599L (no) Vaksine
DE69835346D1 (de) Vakzine gegen infektiöse bursitis
ATE345815T1 (de) Kombinierte impfstoffe gegen hepatitis a und hepatitis b
EP1105154A4 (de) Impfstoffe gegen bakterielle superantigene
DE69831124D1 (de) Bläsergehäuse
ATE431415T1 (de) Hiv impfstoff
ITMI981384A0 (it) Vaccino per hiv
KR970703417A (ko) 유두종 바이러스 백신(Papillomavirus vaccines)
FI4197U1 (fi) Puhalluslaite
ITMI992410A0 (it) Vaccino per hiv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PFIZER AG, ZUERICH, CH